NCT06577623

Brief Summary

Adolescents with ASD often have co-occurring mental health symptoms like stress, anxiety, and depression. The investigators are conducting this research study to develop interventions for adolescents with ASD that will improve co-occurring mental health symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 27, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

August 27, 2024

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mean Change from Baseline in Children's Depression Inventory (CDI) Scores

    Parent-report measure of adolescent depressive symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of depression symptoms.

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores

    Parent-report measure of adolescent anxiety symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of anxiety symptoms.

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores

    Adolescent-report measure of mindfulness. Scores range from 0 to 40 with higher scores indicating higher levels of mindfulness.

    Post-intervention (8 weeks); 2-month follow-up

Secondary Outcomes (7)

  • Mean Change from Baseline in Beck Youth Inventories (BYI) Scores

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in World Health Organization-Five Wellbeing Index (WHO-5) Scores

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in Adaptive Behavior Assessment System (ABAS-3) Scores

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores

    Post-intervention (8 weeks); 2-month follow-up

  • Mean Change from Baseline in Five Facets Mindfulness Questionnaire (FFMQ) Scores

    Post-intervention (8 weeks); 2-month follow-up

  • +2 more secondary outcomes

Study Arms (1)

MINDful TIME group

EXPERIMENTAL

8-week mindfulness-based intervention for adolescents with ASD and their caregivers. Weekly meetings will be held in-person and will last approximately 2-hours. Adolescents and their caregivers will be asked to engage in home practice outside of group meetings

Behavioral: MINDful TIME

Interventions

MINDful TIMEBEHAVIORAL

Group-based psychoeducational mindfulness-based intervention.

MINDful TIME group

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescents must be ages 13 to 18 years
  • Formal clinical or educational ASD diagnosis confirmed by the study team (i.e., review of the formal diagnostic or educational report)
  • Must be able to attend at least 7 of the 8 in-person group meetings
  • English speaking: Adolescents and their parent/caregivers must be English-speaking because the screening and behavioral measures are in English, as well as the intervention content

You may not qualify if:

  • Non-verbal participants will be excluded to ensure test compliance and increase sample homogeneity.
  • Participants with IQ scores \<70 will be excluded because the intervention was developed for individuals without intellectual disabilities.
  • Participants with a physical disability or co-occurring condition that may prevent participation in the weekly group meetings (e.g., selective mutism; aggressive behavior; inability to participate in a 90-minute video conference meeting each week)
  • Participants who report active suicidal ideation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southwest Autism Research and Resource Center

Phoenix, Arizona, 85006, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Nicole Matthews, Ph.D.

    Southwest Autism Research & Resource Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Open label feasibility and acceptability trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2024

First Posted

August 29, 2024

Study Start

August 14, 2024

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Locations